ArticlemedRxiv : the preprint server for health sciences2024
Assessing the clinical meaningfulness of slowing CDR-SB progression with disease-modifying therapies for Alzheimer disease.
Sarah M Hartz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.